Progyny, Inc. Cash and Short Term Investments

Cash and Short Term Investments of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash and Short Term Investments growth rates and interactive chart. Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities. Cash and short term investments are considered very liquid assets.

Highlights and Quick Summary

  • Cash and Short Term Investments for the quarter ending September 29, 2021 was $114 Million (a 21.65% increase compared to previous quarter)
  • Year-over-year quarterly Cash and Short Term Investments increased by 4.58%
  • Annual Cash and Short Term Investments for 2020 was $109 Million (a 35.97% increase from previous year)
  • Annual Cash and Short Term Investments for 2019 was $80.4 Million (a 63192.91% increase from previous year)
  • Annual Cash and Short Term Investments for 2018 was $127 Thousand (a -97.29% decrease from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash and Short Term Investments of Progyny, Inc.

Most recent Cash and Short Term Investmentsof PGNY including historical data for past 10 years.

Interactive Chart of Cash and Short Term Investments of Progyny, Inc.

Progyny, Inc. Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 – $114.31 $93.97 $106.92 –
2020 $109.3 $104.96 $91.38 $91.63 $109.3
2019 – $80.38 $7.66 $0.3 $80.38
2018 – – – $0.13 $0.13
2017 $4.69 – – – $4.69

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
© stockrow.com